Current Evidence for Antithrombotic Therapy after Peripheral Vascular Interventions

E-ISSN： 1875-6212|11|4|507-513

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.11, Iss.4, 2013-07, pp. : 507-513

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Management of Peripheral Vascular Disease: Where is the Evidence?

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 9, Iss. 2, 2011-01 ,pp. : 128-136

Bentham Science Publishers

Access to resources Recommend Favorite

Antithrombotic therapy in peripheral artery disease: A review of the EUCLID trial results and current ongoing trials

Clinical Cardiology, Vol. 41, Iss. 1, 2018-01 ,pp. : 137-143

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antithrombotic Therapy for Transcatheter Valvular Interventions: A Revisit

Current Vascular Pharmacology, Vol. 16, Iss. 2, 2018-01 ,pp. : 107-113

Bentham Science Publishers

Access to resources Recommend Favorite

The Unaddressed Issue of Optimal Antithrombotic Treatment after Coronary Artery Stenting in Patients with an Indication for Anticoagulation: Current Evidence and Suggested Practice

Vascular Disease Prevention, Vol. 3, Iss. 2, 2006-05 ,pp. : 153-158

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Antithrombotic Therapy: Current and Future Clinical Use)

Current Vascular Pharmacology, Vol. 12, Iss. 3, 2014-05 ,pp. : 351-352

Bentham Science Publishers

Access to resources Recommend Favorite